Magnisense has developed and demonstrated a novel diagnostic technology which promises to revolutionize the immunoassay diagnostic test. The dramatic performance improvement which the Magnisense MIAtek™ technology has achieved in all critical parameters of rapid test performance enables a multitude of new test applications in a variety of formats.
Quantified results, secure data transmission and increased sensitivity in a robust portable diagnostic device permit now:
- Quantified Point of Care testing at increased reliability for applications such as vaccination control, microbial or viral infection detection, humoral markers quantification.
- Faster and quantified bacteria detection in, e.g., agro-food products, water.
We invite you to evaluate what we believe to be the
Next generation bioassay™.